CBT
DGX icon

Capital Bank & Trust’s Quest Diagnostics DGX Stock Holding History

Capital Bank & Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-80
Closed -$6K – 381
2020
Q1 		$6K Buy
80
+14
+21% +$1.45K ﹤0.01% 580
2019
Q4 		$7K Sell
66
-32
-33% -$3.34K ﹤0.01% 583
2019
Q3 		$10K Buy
98
+32
+48% +$3.29K ﹤0.01% 552
2019
Q2 		$7K Hold
66
– – ﹤0.01% 565
2019
Q1 		$6K Hold
66
– – ﹤0.01% 574
2018
Q4 		$5K Hold
66
– – ﹤0.01% 609
2018
Q3 		$7K Hold
66
– – ﹤0.01% 691
2018
Q2 		$7K Hold
66
– – ﹤0.01% 559
2018
Q1 		$7K Hold
66
– – ﹤0.01% 542
2017
Q4 		$7K Buy
+66
New +$6.26K ﹤0.01% 577
2017
Q3 		– Sell
-17
Closed -$2K – 600
2017
Q2 		$2K Buy
+17
New +$1.8K ﹤0.01% 543

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Bank & Trust's DGX Position: Q2 2020 in Review

Capital Bank & Trust sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 80 shares — an estimated $6K sold.

Capital Bank & Trust first reported a position in DGX in Q2 2017 and held it in 11 quarters. The position peaked at $10K in Q3 2019. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Capital Bank & Trust reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 80 Quest Diagnostics shares in Q2 2020, an estimated $6K.
  • Capital Bank & Trust first reported a position in Quest Diagnostics in Q2 2017 and held it in 11 quarters.
  • Capital Bank & Trust's Quest Diagnostics position peaked at $10K in Q3 2019.
  • 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.